Figures & Tables
Figures
- FIGURE 1
Public‐Sector Injectables Prevalence Rate Estimates
- FIGURE 2
Public‐Sector Oral Contraceptive Prevalence Rate Estimates
- FIGURE 3
Public‐Sector Male Condom Prevalence Rate Estimates
- FIGURE 4
CPR Estimates for Public‐Sector Short‐Acting Methods
- APPENDIX FIGURE 1.
Difference Between Model‐Generated and Referent DHS Public Injectables Prevalence Rate
- APPENDIX FIGURE 2.
Difference Between Model‐Generated and Referent DHS Public Oral Contraceptives Prevalence Rate
- APPENDIX FIGURE 3.
Difference Between Model‐Generated and Referent DHS Public Condoms Prevalence Rate
Tables
Country Country Code DHS Collection Dates Previous DHS Contraceptive Logistics Data Source Logistics Data Dates Bangladesh BD 7/2011–12/2011 2007 PPMR 6/2011–12/2011 Bolivia BO 8/2003–1/2004 1998 PipeLine 7/2003–2/2004 Burkina Faso BF 5/2010–12/2010 2003 PipeLine 4/2010–1/2011 Cameroon CM 2/2004–9/2004 1998 PipeLine 1/2004–10/2004 Côte d'Ivoire CI 12/2011–5/2012 1998–99 PPMR 11/2011–6/2012 Ethiopia ET 4/2011–9/2011 2005 PPMR 1/2011–1/2012 Ghana GH 9/2008–11/2008 2003 PipeLine 8/2008–12/2008 Guinea GN 2/2005–6/2005 1999 PipeLine 1/2005–7/2005 Haiti HT 1/2012–6/2012 2007 PPMR 3/2011–9/2012 Honduras HN 10/2005–5/2006 ‐‐ PipeLine 9/2005–6/2006 Jordan JO 7/2002–10/2002 1997 PipeLine 6/2002–11/2002 Kenya KE 11/2008–3/2009 2003 PPMR 10/2008–5/2009 Liberia LR 12/2006–4/2007 ‐‐ PipeLine 11/2006–5/2007 Madagascar MD 11/2008–7/2009 2005 PipeLine 10/2008–8/2009 Malawi MW 6/2010–10/2010 2006 PPMR 5/2010–11/2010 Mali ML 4/2006–12/2006 2001 PipeLine 3/2006–12/2006 Mozambique MZ 5/2011–12/2011 2005 PPMR 4/2011–6/2011 Nepal NP 1/2011–6/2011 2006 PPMR 1/2011–7/2011 Nicaragua NC 9/2001–12/2001 1998–99 PipeLine 8/2001–1/2002 Niger NI 2/2012–7/2012 2006 PPMR 6/2013 Nigeria NG 6/2008–11/2008 2003 PipeLine 7/2008–12/2008 Pakistan PK 10/2012–4/2013 2006–07 PPMR 12/2012–3/2012 Philippines PH 6/2003–9/2003 1998 PipeLine 2/2003–11/2003 Rwanda RW 9/2010–4/2011 2009 PPMR 6/2010–5/2011 Senegal SN 10/2010–5/2011 2005 PPMR 7/2010–7/2011 Tanzania TZ 12/2009–5/2010 2006 PPMR 9/2009–6/2010 Togo TG 2/1998–5/1998 1988 PipeLine 1/1998–6/1998 Uganda UG 6/2011–12/2011 2006 PPMR 1/2011–12/2011 Zambia ZM 4/2007–10/2007 2003 PipeLine 3/2007–11/2007 Zimbabwe ZW 9/2010–3/2011 2007 PPMR 6/2010–6/2011 Abbreviations: DHS, Demographic and Health Surveys; PipeLine, Pipeline Monitoring and Procurement Planning System; PPMR, Procurement Planning and Monitoring Report.
- TABLE 2 Modern Contraceptive Prevalence Rate (mCPR), Prevalence Rates of Short‐Acting Methods, and Public‐Sector Market Share, by Country, From DHS
Prevalence (%) Public‐Sector Prevalence (%) Public‐Sector Market Share (%) Country mCPR (%) OC IC MC OC IC MC OC IC MC Bangladesh 52.1 27.2 11.2 5.5 12.2 7.4 0.9 45.0 66.5 16.8 Bolivia 23.7 2.5 5.3 3.1 0.8 4.0 0.2 31.5 74.5 7.5 Burkina Faso 14.3 2.8 5.1 3.1 2.3 5.0 0.3 83.4 97.3 8.9 Cameroon 13.5 1.3 1.1 9.7 0.6 0.8 0.6 49.3 75.0 6.4 Côte d'Ivoire 13.9 6.1 1.9 5.0 1.4 1.7 0.2 23.4 89.2 4.2 Ethiopia 18.7 1.5 14.0 0.3 1.0 12.1 0.0 67.3 86.3 11.7 Ghana 13.5 3.6 4.2 3.6 0.5 3.7 0.1 12.8 87.0 2.7 Guinea 6.8 1.6 1.1 2.5 0.7 0.9 0.2 42.0 86.2 7.5 Haiti 21.6 1.7 11.7 5.8 0.4 5.5 0.7 22.4 46.6 11.2 Honduras 37.7 7.1 8.6 2.3 2.0 6.2 0.6 28.4 72.2 24.2 Jordan 41.2 7.5 0.9 3.4 2.7 0.4 1.3 36.5 46.7 37.3 Kenya 28.0 4.7 14.8 2.6 2.0 9.7 0.5 42.6 65.3 20.5 Liberia 11.7 3.8 3.7 3.5 2.2 2.6 1.4 56.8 69.1 40.9 Madagascar 23.0 4.8 14.1 1.0 2.8 11.7 0.0 57.3 82.9 4.9 Malawi 32.6 1.9 19.2 2.7 1.6 16.2 1.2 81.8 84.4 46.1 Mali 6.2 2.6 2.2 0.5 1.0 1.7 0.0 36.8 76.7 3.7 Mozambique 12.1 4.3 4.3 2.9 3.7 4.1 1.0 86.2 95.4 34.8 Nepal 33.2 3.2 7.0 3.3 1.6 4.8 1.1 50.9 69 32.3 Nicaragua 43.9 9.0 9.1 2.2 5.3 6.8 0.8 59.4 74.3 35.8 Niger 11.0 5.0 1.9 0.1 4.1 1.8 0.1 82.9 94.4 69.2 Nigeria 11.1 1.6 2.0 4.7 0.3 1.1 0.2 19.0 54.7 4.0 Pakistan 26.1 1.6 2.8 8.8 0.8 1.6 1.6 47.7 56.5 17.8 Philippines 23.5 8.4 2.0 1.2 4.8 1.9 0.3 56.6 92.5 27.4 Rwanda 25.2 3.9 14.6 1.8 3.7 14.2 0.9 94.2 97.1 51.4 Senegal 8.9 2.9 3.7 0.6 2.4 3.5 0.1 82.4 94.8 20.7 Tanzania 23.6 5.1 8.5 4.2 3.7 6.8 0.7 73.5 80.0 17.0 Togo 7.9 1.1 1.7 3.4 0.4 1.6 0.5 39.5 91.6 15.0 Uganda 20.7 2.1 10.7 3.2 1.0 4.2 0.9 45.7 39.1 28.6 Zambia 24.6 7.4 6.2 5.0 4.5 5.7 2.6 61.3 92.1 51.7 Zimbabwe 40.5 27.3 6.1 3.5 20.2 5.4 1.6 73.8 88.4 45.9 Abbreviations: CPR, contraceptive prevalence rate; DHS, Demographic and Health Surveys; IC, injectable contraceptives; MC, male condoms; mCPR, CPR for modern methods; OC, oral contraceptives.
- TABLE 3 Association Between Referent Public‐Sector Prevalence Rates and Average Monthly or Quarterly Logistics Distribution Data, by Contraceptive Type and Model Type
Model and Contraceptive Type N β0 β1 β2 R2‐adj Bivariate Model Injectable contraceptives 30 −4.11 0.72*** NA 0.90 Oral contraceptivesa 27 −4.46 0.45*** NA 0.48 Male condoms 28 −6.49 0.44*** NA 0.28 Multivariate Model Injectable contraceptives 28 −4.21 0.62*** 5.7 0.91 Oral contraceptivesa 25 −4.97 0.23* 34.93*** 0.72 Male condoms 26 −6.66 0.19 171.93*** 0.48 Difference Between Model Estimates and DHS Referent Values Proportion of Model‐Estimated Values Within 1, 2, and 5 Percentage Points of the DHS Value Model Maximum Absolute Error (%) Mean Absolute Error (MAE) (%) Median Absolute Error (%) 1 Percentage Point (%) 2 Percentage Points (%) 5 Percentage Points (%) Injectables Multivariate 3.8 1.0 0.6 57 89 100 Bivariate 7.0 1.1 0.7 57 90 97 CYP 8.6 1.4 0.8 54 86 93 Oral Contraceptives Multivariate 2.9 0.6 0.4 84 92 100 Bivariate 3.0 0.9 0.6 67 89 100 CYP 3.4 1.0 0.8 60 92 100 Condoms Multivariate 1.3 0.3 0.2 92 100 100 Bivariate 1.9 0.4 0.3 93 100 100 CYP 14.4 2.4 0.6 62 77 85 All Short-Acting Methods Multivariate 4.6 1.4 1.3 35 74 100 Bivariate 7.8 1.9 1.2 40 64 88 CYP 17.0 3.4 1.5 43 61 78
GHSP-D-15-00116 Supplementary Material
Levine et al. doi: 10.9745/GHSP-D-15-00116
- Supplementary Material - Cunningham et al. doi: 10.9745/GHSP-D-15-00116
- Supplementary Material - Cunningham et al. doi: 10.9745/GHSP-D-15-00116
- Supplementary Material - Cunningham et al. doi: 10.9745/GHSP-D-15-00116
- Supplementary Material - Cunningham et al. doi: 10.9745/GHSP-D-15-00116
